Article
Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b.
Polskie Archiwum Medycyny Wewnetrznej - 1 Dec 2011
Mach Tomasz H, Cieśla Andrzej, Warunek Wioleta, Janas-Skulina Urszula, Cibor Dorota, Owczarek Danuta, Ciećko-Michalska Irena
Abstract excerpt
INTRODUCTION: Treatment of chronic hepatitis C (CHC) with pegylated interferon (Peg-IFN) and ribavirin leads to sustained virological response (SVR) in approximately 50% of the patients. SVR depends on hepatitis C virus (HCV) and host factors, including IL28B genotypes. OBJECTIVES: The aim of the study was to investigate the therapeutic efficacy of the difficult-to-treat HCV genotype 1b in patients from the south...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.